152 related articles for article (PubMed ID: 7671316)
1. Transforming growth factor-beta-mediated regulation of human peripheral blood mononuclear cell proliferation as detected with phosphorothioate antisense oligodeoxynucleotides.
Jachimczak P; Fabel-Schulte K; Hessdörfer B; Brysch W; Schlingensiepen KH; Blesch A; Bogdahn U
Cell Immunol; 1995 Oct; 165(1):125-33. PubMed ID: 7671316
[TBL] [Abstract][Full Text] [Related]
2. Transforming growth factor-beta-mediated autocrine growth regulation of gliomas as detected with phosphorothioate antisense oligonucleotides.
Jachimczak P; Hessdörfer B; Fabel-Schulte K; Wismeth C; Brysch W; Schlingensiepen KH; Bauer A; Blesch A; Bogdahn U
Int J Cancer; 1996 Jan; 65(3):332-7. PubMed ID: 8575854
[TBL] [Abstract][Full Text] [Related]
3. Specific inhibition of transforming growth factor-beta2 expression in human osteoblast cells by antisense phosphorothioate oligonucleotides.
Shen ZJ; Kim SK; Kwon OS; Lee YS; Moon BJ
Eur J Biochem; 2001 Apr; 268(8):2331-7. PubMed ID: 11298751
[TBL] [Abstract][Full Text] [Related]
4. Antitumor effect of c-myc antisense phosphorothioate oligodeoxynucleotides on human melanoma cells in vitro and and in mice.
Leonetti C; D'Agnano I; Lozupone F; Valentini A; Geiser T; Zon G; Calabretta B; Citro G C; Zupi G
J Natl Cancer Inst; 1996 Apr; 88(7):419-29. PubMed ID: 8618233
[TBL] [Abstract][Full Text] [Related]
5. Antiproliferative effect of c-myc antisense phosphorothioate oligodeoxynucleotides in malignant glioma cells.
Broaddus WC; Chen ZJ; Prabhu SS; Loudon WG; Gillies GT; Phillips LL; Fillmore H
Neurosurgery; 1997 Oct; 41(4):908-15. PubMed ID: 9316053
[TBL] [Abstract][Full Text] [Related]
6. The effect of transforming growth factor-beta 2-specific phosphorothioate-anti-sense oligodeoxynucleotides in reversing cellular immunosuppression in malignant glioma.
Jachimczak P; Bogdahn U; Schneider J; Behl C; Meixensberger J; Apfel R; Dörries R; Schlingensiepen KH; Brysch W
J Neurosurg; 1993 Jun; 78(6):944-51. PubMed ID: 8487077
[TBL] [Abstract][Full Text] [Related]
7. [An EGFR antisense oligodeoxynucleotides and its phosphorothioate analogue inhibit the growth of human hepatocarcinoma BEL-7404 cells].
Lin JQ; Xu ZS; Zhang HY; Yang ZW; Xu YH
Shi Yan Sheng Wu Xue Bao; 1995 Sep; 28(3):241-6. PubMed ID: 8571707
[TBL] [Abstract][Full Text] [Related]
8. Antisense oligonucleotides specific for transforming growth factor beta2 inhibit the growth of malignant mesothelioma both in vitro and in vivo.
Marzo AL; Fitzpatrick DR; Robinson BW; Scott B
Cancer Res; 1997 Aug; 57(15):3200-7. PubMed ID: 9242450
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of transforming growth factor-beta 1 alters the growth, anchor-dependent cell aggregation and integrin mRNA expression in human promonocytes: implications for endometriosis and peritoneal adhesion formation.
Dou Q; Williams RS; Chegini N
Mol Hum Reprod; 1997 May; 3(5):383-91. PubMed ID: 9239722
[TBL] [Abstract][Full Text] [Related]
10. Antisense oligonucleotides to CRABP I and II alter the expression of TGF-beta 3, RAR-beta, and tenascin in primary cultures of embryonic palate cells.
Nugent P; Greene RM
In Vitro Cell Dev Biol Anim; 1995; 31(7):553-8. PubMed ID: 8528505
[TBL] [Abstract][Full Text] [Related]
11. Effects of BCR-ABL antisense oligonucleotides (AS-ODN) on human chronic myeloid leukemic cells: AS-ODN as effective purging agents.
Wu AG; Joshi SS; Chan WC; Iversen PL; Jackson JD; Kessinger A; Pirruccello SJ; Sanger WG; Sharp JG; Verbik DJ
Leuk Lymphoma; 1995 Dec; 20(1-2):67-76. PubMed ID: 8750625
[TBL] [Abstract][Full Text] [Related]
12. Effect of antisense TGF-beta1 oligodeoxynucleotides in streptozotocin- induced diabetic rat kidney.
Jeong HS; Park KK; Park KK; Kim SP; Choi IJ; Lee IK; Kim HC
J Korean Med Sci; 2004 Jun; 19(3):374-83. PubMed ID: 15201503
[TBL] [Abstract][Full Text] [Related]
13. Insulin-like growth factor binding protein 3 mediates retinoic acid- and transforming growth factor beta2-induced growth inhibition in human breast cancer cells.
Gucev ZS; Oh Y; Kelley KM; Rosenfeld RG
Cancer Res; 1996 Apr; 56(7):1545-50. PubMed ID: 8603400
[TBL] [Abstract][Full Text] [Related]
14. Antisense phosphorothioate oligodeoxynucleotide down-regulation of the insulin-like growth factor I receptor in ovarian cancer cells.
Müller M; Dietel M; Turzynski A; Wiechen K
Int J Cancer; 1998 Aug; 77(4):567-71. PubMed ID: 9679760
[TBL] [Abstract][Full Text] [Related]
15. Down-regulation of transforming growth factor-beta gene expression by antisense oligodeoxynucleotides increases recombinant interferon-gamma-induced nitric oxide synthesis in murine peritoneal macrophages.
Jun CD; Choi BM; Kim SU; Lee SY; Kim HM; Chung HT
Immunology; 1995 May; 85(1):114-9. PubMed ID: 7635512
[TBL] [Abstract][Full Text] [Related]
16. Release of early human hematopoietic progenitors from quiescence by antisense transforming growth factor beta 1 or Rb oligonucleotides.
Hatzfeld J; Li ML; Brown EL; Sookdeo H; Levesque JP; O'Toole T; Gurney C; Clark SC; Hatzfeld A
J Exp Med; 1991 Oct; 174(4):925-9. PubMed ID: 1717634
[TBL] [Abstract][Full Text] [Related]
17. Effect of Nma on growth inhibition by TGF-betaa in human gastric carcinoma cell lines.
Sasaki T; Sasahira T; Shimura H; Ikeda S; Kuniyasu H
Oncol Rep; 2004 Jun; 11(6):1219-23. PubMed ID: 15138559
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of wound-induced expression of transforming growth factor-beta 1 mRNA by its antisense oligonucleotides.
Kim HM; Choi DH; Lee YM
Pharmacol Res; 1998 Apr; 37(4):289-93. PubMed ID: 9634645
[TBL] [Abstract][Full Text] [Related]
19. Effect of cisplatin and c-myb antisense phosphorothioate oligodeoxynucleotides combination on a human colon carcinoma cell line in vitro and in vivo.
Del Bufalo D; Cucco C; Leonetti C; Citro G; D'Agnano I; Benassi M; Geiser T; Zon G; Calabretta B; Zupi G
Br J Cancer; 1996 Aug; 74(3):387-93. PubMed ID: 8695353
[TBL] [Abstract][Full Text] [Related]
20. Effect of TGF-beta(1) antisense S-oligonucleotide on synthesis and accumulation of matrix proteoglycans in balloon catheter-injured neointima of rabbit carotid arteries.
Merrilees M; Beaumont B; Scott L; Hermanutz V; Fennessy P
J Vasc Res; 2000; 37(1):50-60. PubMed ID: 10720886
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
